ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,437,232 | +645.9% | 212,919 | +757.2% | 0.01% | +500.0% |
| Q2 2023 | $594,894 | +21.6% | 24,839 | -19.1% | 0.00% | -33.3% |
| Q4 2022 | $489,078 | +57.3% | 30,721 | +139.5% | 0.00% | 0.0% |
| Q1 2022 | $311,000 | -87.9% | 12,825 | -73.4% | 0.00% | -91.9% |
| Q4 2020 | $2,578,000 | -67.1% | 48,226 | -70.1% | 0.04% | -67.8% |
| Q2 2020 | $7,825,000 | +2980.7% | 161,431 | +2617.7% | 0.12% | +1337.5% |
| Q4 2019 | $254,000 | – | 5,940 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |